Genetic Variants in Matrix Metalloproteinase Genes as Disposition Factors for Ovarian Cancer Risk, Survival, and Clinical Outcome

Molecular Carcinogenesis - United States
doi 10.1002/mc.22111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Matrix Metalloproteinase Expressions Play Important Role in Prediction of Ovarian Cancer Outcome

Scientific Reports
Multidisciplinary
2019English

E-Cadherin Genetic Variants Predict Survival Outcome in Breast Cancer Patients

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Heterogeneity of Germline Variants in High Risk Breast and Ovarian Cancer Susceptibility Genes in India

Precision Clinical Medicine
2018English

Evaluation of Genetic Variants in Association With Colorectal Cancer Risk and Survival in Asians

International Journal of Cancer
Cancer ResearchOncology
2017English

Breast Cancer Risk Assessment Using Genetic Variants and Risk Factors in a Singapore Chinese Population

Breast Cancer Research
Cancer ResearchOncology
2014English

Plasma Matrix Metalloproteinase 2 Levels and Breast Cancer Risk

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2015English

Telomere Length and Genetic Variation in Telomere Maintenance Genes in Relation to Ovarian Cancer Risk

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Genetic Variants in FGFR2 and FGFR4 Genes and Skin Cancer Risk in the Nurses' Health Study

BMC Cancer
Cancer ResearchOncologyGenetics
2009English

The Estrogen Receptor and Its Variants as Risk Factors in Breast Cancer

2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy